Randomized, controlled trial including an initial 4-week daily "induction" period during one year of high-dose interferon alfa-2b treatment for chronic hepatitis C

Chronic Hepatitis ◽

Hepatitis C ◽

Induction Period ◽

Controlled Trial ◽

Interferon Alfa ◽

High Dose ◽

Randomized Controlled ◽

One Year ◽

High Dose Interferon

Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon‐α in interferon nonresponders with chronic hepatitis C

Journal of Viral Hepatitis ◽

10.1046/j.1365-2893.1999.00005.x ◽

1999 ◽

Vol 6 (s1) ◽

pp. 53-58 ◽

Cited By ~ 12

Author(s):

P. Ferenci ◽

R. Stauber ◽

P. Steindl‐Munda ◽

M. Gschwantler ◽

P. Fickert ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interim Analysis ◽

Controlled Trial ◽

Interferon Α ◽

High Dose ◽

Randomized Controlled ◽

High Dose Interferon

Sequential versus concomitant administration of ribavirin and interferon alfa-N3 in patients with chronic hepatitis C not responding to interferon alone. Results of a randomized controlled trial

Gastroenterology ◽

10.1016/s0016-5085(98)85458-9 ◽

1998 ◽

Vol 114 ◽

pp. A1344

Author(s):

Raffaello Sostegni ◽

Valeria Ghisetti ◽

Fabrizia Pittaluga ◽

Giovanna Marchiaro ◽

Giuseppe Rocca ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Concomitant Administration ◽

Interferon Alfa ◽

Randomized Controlled

Comparative efficacy of high and low dose of interferon alfa-2b in chronic hepatitis C: A randomized controlled trial NC Tassopoulos, G Karvountzis. G Touloumi, J Delladetsima****, GV Papatheodoridis, A Katsoulidou, G Retalis, A Hatzakis. First Dept. of Medicine, Western Attica General Hospital, Athens, State Dept. of Medicine, Hippokration General Hospital, Athens, Dept. of Hygiene and Epidemiology, Athens University Medical School, Athens, Laboratory of Pathology, Laikon General Hospital, Athens, Schering-Plough, Athens, Greece

Hepatology ◽

10.1016/0270-9139(95)94182-7 ◽

1995 ◽

Vol 22 (4) ◽

pp. A114

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Medical School ◽

General Hospital ◽

Low Dose ◽

Controlled Trial ◽

Interferon Alfa ◽

Comparative Efficacy ◽

Randomized Controlled

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

Hepatology ◽

10.1002/hep.510270429 ◽

1998 ◽

Vol 27 (4) ◽

pp. 1121-1127 ◽

Cited By ~ 44

Author(s):

Geoffrey C. Farrell ◽

Bruce R. Bacon ◽

Robert D. Goldin ◽

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Controlled Trial ◽

Interferon Alfa ◽

Recombinant Interferon ◽

Randomized Controlled ◽

Term Response ◽

Lymphoblastoid Interferon

High-dose IFN-A induction followed by IFN plus ribavirin in treatment-naive patients with chronic hepatitis C: A prospective, randomized, controlled trial

Gastroenterology ◽

10.1016/s0016-5085(00)85928-4 ◽

2000 ◽

Vol 118 (4) ◽

pp. A946-A947

Author(s):

Steven L. Flamm ◽

Hari Conjeevaram ◽

Thelma E. Wiley ◽

Daniel Ganger ◽

Ken O'Riordan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

High Dose ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial ◽

Treatment Naïve

Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6

Hepatology ◽

10.1002/hep.23889 ◽

2010 ◽

Vol 52 (5) ◽

pp. 1573-1580 ◽

Cited By ~ 28

Author(s):

Khoa D. Lam ◽

Huy N. Trinh ◽

Son T. Do ◽

Thuan T. Nguyen ◽

Ruel T. Garcia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Randomized Controlled ◽

Treatment Naïve ◽

Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected PatientsA Randomized Controlled Trial

JAMA ◽

10.1001/jama.292.23.2839 ◽

2004 ◽

Vol 292 (23) ◽

pp. 2839 ◽

Cited By ~ 600

Author(s):

Fabrice Carrat

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Standard Interferon ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6210956.6276054 ◽

2011 ◽

Author(s):

William Lee ◽

He-Jun Yuan

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Randomized Controlled ◽

Treatment Naïve ◽

Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin—A Multicenter Study

Journal of Clinical and Experimental Hepatology ◽

10.1016/s0973-6883(12)60079-6 ◽

2012 ◽

Vol 2 (1) ◽

pp. 10-18 ◽

Cited By ~ 5

Author(s):

Subrat K Acharya ◽

V Sreenivas ◽

Siddharth Datta Gupta ◽

Shakti Kumar ◽

Yogesh K Chawla ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Multicenter Study ◽

Controlled Trial ◽

Interferon Alfa ◽

Randomized Controlled

Retreatment with pegylated interferon alfa-2B plus ribavirin with or without amantadine of patients with chronic hepatitis C relapsing after standard interferon and ribavirin: Results of a randomized controlled trial

Digestive and Liver Disease ◽

10.1016/s1590-8658(06)80279-3 ◽

2006 ◽

Vol 38 ◽

pp. S104-S105

Author(s):

A. Ciancio ◽

C. Giordanino ◽

A. Smedile ◽

M. Tabone ◽

S. Martini ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Standard Interferon ◽

Randomized Controlled ◽